APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Excipients for Oral Formulations

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pharmaceutical Excipients for Oral Formulations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025182 pages

Choose your research edition.

Industry ResearchPharmaceutical Excipients for Oral Formulations Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Excipients for Oral Formulations Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Excipients for Oral Formulations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Excipients for Oral Formulations Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Excipients for Oral Formulations Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Pharmaceutical Excipients for Oral Formulations market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pharmaceutical Excipients for Oral Formulations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Excipients for Oral Formulations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Excipients for Oral Formulations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pharmaceutical Excipients for Oral Formulations is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pharmaceutical Excipients for Oral Formulations include BASF, Archer Daniels Midland, Evonik Industries, Lubrizol, Roquette and DowDupont, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Excipients for Oral Formulations market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Excipients for Oral Formulations and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Excipients for Oral Formulations sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Excipients for Oral Formulations market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Excipients for Oral Formulations Segment by Company

BASF

Archer Daniels Midland

Evonik Industries

Lubrizol

Roquette

DowDupont

Pharmaceutical Excipients for Oral Formulations Segment by Type

Tablets

Capsules

Pharmaceutical Excipients for Oral Formulations Segment by Application

E-Commerce

Retail Stores

Drug Stores

Hospital Pharmacies

Pharmaceutical Excipients for Oral Formulations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Excipients for Oral Formulations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Excipients for Oral Formulations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Excipients for Oral Formulations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Excipients for Oral Formulations market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pharmaceutical Excipients for Oral Formulations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pharmaceutical Excipients for Oral Formulations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pharmaceutical Excipients for Oral Formulations in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Excipients for Oral Formulations Industry Trends Table 2. Pharmaceutical Excipients for Oral Formulations Industry Drivers Table 3. Pharmaceutical Excipients for Oral Formulations Industry Opportunities and Challenges Table 4. Pharmaceutical Excipients for Oral Formulations Industry Restraints Table 5. Global Pharmaceutical Excipients for Oral Formulations Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pharmaceutical Excipients for Oral Formulations Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Manufacturers Table 9. Global Pharmaceutical Excipients for Oral Formulations Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Pharmaceutical Excipients for Oral Formulations Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pharmaceutical Excipients for Oral Formulations Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pharmaceutical Excipients for Oral Formulations Manufacturers, Product Type & Application Table 13. Global Pharmaceutical Excipients for Oral Formulations Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Excipients for Oral Formulations by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Capsules Table 18. Global Pharmaceutical Excipients for Oral Formulations Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Pharmaceutical Excipients for Oral Formulations Sales by Type (2021-2026) & (k units) Table 20. Global Pharmaceutical Excipients for Oral Formulations Sales by Type (2027-2032) & (k units) Table 21. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2021-2026) Table 22. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2027-2032) Table 23. Global Pharmaceutical Excipients for Oral Formulations Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Pharmaceutical Excipients for Oral Formulations Revenue by Type (2021-2026) & (k units) Table 25. Global Pharmaceutical Excipients for Oral Formulations Revenue by Type (2027-2032) & (k units) Table 26. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Type (2021-2026) Table 27. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of E-Commerce Table 29. Major Manufacturers of Retail Stores Table 30. Major Manufacturers of Drug Stores Table 31. Major Manufacturers of Hospital Pharmacies Table 32. Global Pharmaceutical Excipients for Oral Formulations Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Pharmaceutical Excipients for Oral Formulations Sales by Application (2021-2026) & (k units) Table 34. Global Pharmaceutical Excipients for Oral Formulations Sales by Application (2027-2032) & (k units) Table 35. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2021-2026) Table 36. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2027-2032) Table 37. Global Pharmaceutical Excipients for Oral Formulations Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Pharmaceutical Excipients for Oral Formulations Revenue by Application (2021-2026) & (k units) Table 39. Global Pharmaceutical Excipients for Oral Formulations Revenue by Application (2027-2032) & (k units) Table 40. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Application (2021-2026) Table 41. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Application (2027-2032) Table 42. Global Pharmaceutical Excipients for Oral Formulations Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Pharmaceutical Excipients for Oral Formulations Sales by Region (2021-2026) & (k units) Table 44. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Region (2021-2026) Table 45. Global Pharmaceutical Excipients for Oral Formulations Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Pharmaceutical Excipients for Oral Formulations Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pharmaceutical Excipients for Oral Formulations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Pharmaceutical Excipients for Oral Formulations Sales by Country (2021-2026) & (k units) Table 49. North America Pharmaceutical Excipients for Oral Formulations Sales by Country (2027-2032) & (k units) Table 50. Europe Pharmaceutical Excipients for Oral Formulations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Pharmaceutical Excipients for Oral Formulations Sales by Country (2021-2026) & (k units) Table 52. Europe Pharmaceutical Excipients for Oral Formulations Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Pharmaceutical Excipients for Oral Formulations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Pharmaceutical Excipients for Oral Formulations Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Pharmaceutical Excipients for Oral Formulations Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Sales by Country (2027-2032) & (k units) Table 59. Global Pharmaceutical Excipients for Oral Formulations Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pharmaceutical Excipients for Oral Formulations Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pharmaceutical Excipients for Oral Formulations Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Region (2021-2026) Table 63. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Region (2027-2032) Table 64. BASF Company Information Table 65. BASF Business Overview Table 66. BASF Pharmaceutical Excipients for Oral Formulations Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. BASF Pharmaceutical Excipients for Oral Formulations Product Portfolio Table 68. BASF Recent Development Table 69. Archer Daniels Midland Company Information Table 70. Archer Daniels Midland Business Overview Table 71. Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Product Portfolio Table 73. Archer Daniels Midland Recent Development Table 74. Evonik Industries Company Information Table 75. Evonik Industries Business Overview Table 76. Evonik Industries Pharmaceutical Excipients for Oral Formulations Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Evonik Industries Pharmaceutical Excipients for Oral Formulations Product Portfolio Table 78. Evonik Industries Recent Development Table 79. Lubrizol Company Information Table 80. Lubrizol Business Overview Table 81. Lubrizol Pharmaceutical Excipients for Oral Formulations Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Lubrizol Pharmaceutical Excipients for Oral Formulations Product Portfolio Table 83. Lubrizol Recent Development Table 84. Roquette Company Information Table 85. Roquette Business Overview Table 86. Roquette Pharmaceutical Excipients for Oral Formulations Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Roquette Pharmaceutical Excipients for Oral Formulations Product Portfolio Table 88. Roquette Recent Development Table 89. DowDupont Company Information Table 90. DowDupont Business Overview Table 91. DowDupont Pharmaceutical Excipients for Oral Formulations Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. DowDupont Pharmaceutical Excipients for Oral Formulations Product Portfolio Table 93. DowDupont Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Pharmaceutical Excipients for Oral Formulations Distributors List Table 97. Pharmaceutical Excipients for Oral Formulations Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Pharmaceutical Excipients for Oral Formulations Product Image Figure 2. Global Pharmaceutical Excipients for Oral Formulations Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Excipients for Oral Formulations Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Excipients for Oral Formulations Sales (2021-2032) & (k units) Figure 5. Global Pharmaceutical Excipients for Oral Formulations Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pharmaceutical Excipients for Oral Formulations Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Capsules Image Figure 10. Global Pharmaceutical Excipients for Oral Formulations Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2021-2032) Figure 13. Global Pharmaceutical Excipients for Oral Formulations Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Type (2021-2032) Figure 16. E-Commerce Image Figure 17. Retail Stores Image Figure 18. Drug Stores Image Figure 19. Hospital Pharmacies Image Figure 20. Global Pharmaceutical Excipients for Oral Formulations Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2021-2032) Figure 23. Global Pharmaceutical Excipients for Oral Formulations Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Application (2021-2032) Figure 26. North America Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country (2021-2032) Figure 28. U.S. Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country (2021-2032) Figure 33. Germany Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country (2021-2032) Figure 40. China Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Sales Market Share by Country (2021-2032) Figure 48. Brazil Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Pharmaceutical Excipients for Oral Formulations Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Pharmaceutical Excipients for Oral Formulations Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pharmaceutical Excipients for Oral Formulations Revenue (2021-2032) & (US$ Million) Figure 59. North America Pharmaceutical Excipients for Oral Formulations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pharmaceutical Excipients for Oral Formulations Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pharmaceutical Excipients for Oral Formulations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pharmaceutical Excipients for Oral Formulations Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pharmaceutical Excipients for Oral Formulations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pharmaceutical Excipients for Oral Formulations Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pharmaceutical Excipients for Oral Formulations Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • E-Commerce
  • Retail Stores
  • Drug Stores
  • Hospital Pharmacies
Companies covered
  • BASF
  • Archer Daniels Midland
  • Evonik Industries
  • Lubrizol
  • Roquette
  • DowDupont

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Excipients for Oral Formulations Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Excipients for Oral Formulations Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pharmaceutical Excipients for Oral Formulations Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pharmaceutical Excipients for Oral Formulations Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pharmaceutical Excipients for Oral Formulations Market Dynamics
  1. 2.1 Pharmaceutical Excipients for Oral Formulations Industry Trends
  2. 2.2 Pharmaceutical Excipients for Oral Formulations Industry Drivers
  3. 2.3 Pharmaceutical Excipients for Oral Formulations Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Excipients for Oral Formulations Industry Restraints
3 Pharmaceutical Excipients for Oral Formulations Market by Manufacturers
  1. 3.1 Global Pharmaceutical Excipients for Oral Formulations Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pharmaceutical Excipients for Oral Formulations Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pharmaceutical Excipients for Oral Formulations Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pharmaceutical Excipients for Oral Formulations Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pharmaceutical Excipients for Oral Formulations Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pharmaceutical Excipients for Oral Formulations Manufacturers, Product Type & Application
  7. 3.7 Global Pharmaceutical Excipients for Oral Formulations Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pharmaceutical Excipients for Oral Formulations Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pharmaceutical Excipients for Oral Formulations Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pharmaceutical Excipients for Oral Formulations Tier 1, Tier 2, and Tier 3
4 Pharmaceutical Excipients for Oral Formulations Market by Type
  1. 4.1 Pharmaceutical Excipients for Oral Formulations Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.2 Global Pharmaceutical Excipients for Oral Formulations Sales by Type
  5. 4.2.1 Global Pharmaceutical Excipients for Oral Formulations Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical Excipients for Oral Formulations Sales by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Type (2021-2032)
  8. 4.3 Global Pharmaceutical Excipients for Oral Formulations Revenue by Type
  9. 4.3.1 Global Pharmaceutical Excipients for Oral Formulations Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharmaceutical Excipients for Oral Formulations Revenue by Type (2021-2032)
  11. 4.3.3 Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Type (2021-2032)
5 Pharmaceutical Excipients for Oral Formulations Market by Application
  1. 5.1 Pharmaceutical Excipients for Oral Formulations Application Introduction
  2. 5.1.1 E-Commerce
  3. 5.1.2 Retail Stores
  4. 5.1.3 Drug Stores
  5. 5.1.4 Hospital Pharmacies
  6. 5.2 Global Pharmaceutical Excipients for Oral Formulations Sales by Application
  7. 5.2.1 Global Pharmaceutical Excipients for Oral Formulations Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pharmaceutical Excipients for Oral Formulations Sales by Application (2021-2032)
  9. 5.2.3 Global Pharmaceutical Excipients for Oral Formulations Sales Market Share by Application (2021-2032)
  10. 5.3 Global Pharmaceutical Excipients for Oral Formulations Revenue by Application
  11. 5.3.1 Global Pharmaceutical Excipients for Oral Formulations Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pharmaceutical Excipients for Oral Formulations Revenue by Application (2021-2032)
  13. 5.3.3 Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Application (2021-2032)
6 Global Pharmaceutical Excipients for Oral Formulations Sales by Region
  1. 6.1 Global Pharmaceutical Excipients for Oral Formulations Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Excipients for Oral Formulations Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Excipients for Oral Formulations Sales by Region (2021-2026)
  4. 6.2.2 Global Pharmaceutical Excipients for Oral Formulations Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Excipients for Oral Formulations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pharmaceutical Excipients for Oral Formulations Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pharmaceutical Excipients for Oral Formulations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pharmaceutical Excipients for Oral Formulations Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pharmaceutical Excipients for Oral Formulations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pharmaceutical Excipients for Oral Formulations Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pharmaceutical Excipients for Oral Formulations Revenue by Region
  1. 7.1 Global Pharmaceutical Excipients for Oral Formulations Revenue by Region
  2. 7.1.1 Global Pharmaceutical Excipients for Oral Formulations Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pharmaceutical Excipients for Oral Formulations Revenue by Region (2021-2026)
  4. 7.1.3 Global Pharmaceutical Excipients for Oral Formulations Revenue by Region (2027-2032)
  5. 7.1.4 Global Pharmaceutical Excipients for Oral Formulations Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pharmaceutical Excipients for Oral Formulations Revenue (2021-2032)
  8. 7.2.2 North America Pharmaceutical Excipients for Oral Formulations Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pharmaceutical Excipients for Oral Formulations Revenue (2021-2032)
  11. 7.3.2 Europe Pharmaceutical Excipients for Oral Formulations Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pharmaceutical Excipients for Oral Formulations Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pharmaceutical Excipients for Oral Formulations Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pharmaceutical Excipients for Oral Formulations Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Pharmaceutical Excipients for Oral Formulations Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BASF Pharmaceutical Excipients for Oral Formulations Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 Archer Daniels Midland
  8. 8.2.1 Archer Daniels Midland Company Information
  9. 8.2.2 Archer Daniels Midland Business Overview
  10. 8.2.3 Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Archer Daniels Midland Pharmaceutical Excipients for Oral Formulations Product Portfolio
  12. 8.2.5 Archer Daniels Midland Recent Developments
  13. 8.3 Evonik Industries
  14. 8.3.1 Evonik Industries Company Information
  15. 8.3.2 Evonik Industries Business Overview
  16. 8.3.3 Evonik Industries Pharmaceutical Excipients for Oral Formulations Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Evonik Industries Pharmaceutical Excipients for Oral Formulations Product Portfolio
  18. 8.3.5 Evonik Industries Recent Developments
  19. 8.4 Lubrizol
  20. 8.4.1 Lubrizol Company Information
  21. 8.4.2 Lubrizol Business Overview
  22. 8.4.3 Lubrizol Pharmaceutical Excipients for Oral Formulations Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lubrizol Pharmaceutical Excipients for Oral Formulations Product Portfolio
  24. 8.4.5 Lubrizol Recent Developments
  25. 8.5 Roquette
  26. 8.5.1 Roquette Company Information
  27. 8.5.2 Roquette Business Overview
  28. 8.5.3 Roquette Pharmaceutical Excipients for Oral Formulations Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roquette Pharmaceutical Excipients for Oral Formulations Product Portfolio
  30. 8.5.5 Roquette Recent Developments
  31. 8.6 DowDupont
  32. 8.6.1 DowDupont Company Information
  33. 8.6.2 DowDupont Business Overview
  34. 8.6.3 DowDupont Pharmaceutical Excipients for Oral Formulations Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 DowDupont Pharmaceutical Excipients for Oral Formulations Product Portfolio
  36. 8.6.5 DowDupont Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Excipients for Oral Formulations Value Chain Analysis
  2. 9.1.1 Pharmaceutical Excipients for Oral Formulations Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Excipients for Oral Formulations Production Mode & Process
  6. 9.2 Pharmaceutical Excipients for Oral Formulations Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Excipients for Oral Formulations Distributors
  9. 9.2.3 Pharmaceutical Excipients for Oral Formulations Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst